Results 111 to 120 of about 262,962 (308)

HAG regimen versus intensive chemotherapy for AML/MDS induction.

, 2016
HAG regimen versus intensive chemotherapy for AML/MDS induction.
Yanlong Zheng (1819264), Jianai Sun (3195636), Wanzhuo Xie (576454), Mixue Xie (3195633), Qi Jiang (33521), Mingyu Zhu (3195627), Lixia Zhu (844549), Xiudi Yang (3195630), Jingjing Zhu (303859), Li Li (14993), Xiujin Ye (576452), De Zhou (3195639)   +11 more
core   +1 more source

MN1, FOXP1 and hsa-miR-181a-5p as prognostic markers in acute myeloid leukemia patients treated with intensive induction chemotherapy and autologous stem cell transplantation.

, 2020
BACKGROUND The meningioma-1 (MN1) gene is expressed in hematopoietic CD34+ cells and down-regulated during myeloid differentiation. MN1 overexpression has been linked to shorter overall and disease free survival in AML patients treated with intensive ...
Pabst, Thomas, Messerli, Christian, Seipel, Katja, Wiedemann, Gertrud, Bacher, Ulrike   +4 more
core   +1 more source

Metastasis on pause: How dormant tumor cells stay hidden within the tumor microenvironment and evade immune surveillance

Molecular Oncology, EarlyView.
Dormant cancer cells can hide in distant organs for years, evading treatment and the immune system. This review highlights how signals from the surrounding tissue and immune environment keep these cells inactive or trigger their reawakening. Understanding these mechanisms may help develop therapies to eliminate or control dormant cells and prevent ...
Kanishka Tiwary, Jose Javier Bravo‐Cordero   +1 more
wiley   +1 more source

Early prediction value of ASL-MRI for induced chemotherapy response and short-term efficacy of locally advanced nasopharyngeal carcinoma

Guangxi Yike Daxue xuebao
Objective To monitor tumor blood flow (TBF) before and after induction chemotherapy in locally advanced nasopharyngeal carcinoma (LA-NPC) by arterial spin labeling magnetic resonance imaging (ASL-MRI), and to investigate the value of ASL-MRI in early ...
SHEN Mingjun, YANG Chaolin, ZHOU Ziyan, WANG Rensheng, KANG Min   +4 more
doaj   +1 more source

Developmental programmes drive cellular plasticity, disease progression and therapy resistance in lung adenocarcinoma

Molecular Oncology, EarlyView.
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska, Stephany Gallardo, Nur S. Zainal, Leena Arora, Matthew Ellis, Maria‐Antoinette Lopez, Judith Austine, Sai Pittla, Serena J Chee, Aiman Alzetani, Emily C Shaw, Christian H Ottensmeier, Gareth J Thomas, Christopher J Hanley   +13 more
wiley   +1 more source

Induction Chemotherapy in Locally Advanced Breast Cancer

, 1994
The definition of locally advanced breast cancer includes stage ⅡB, ⅢA, ⅢB categories, as well as some in the stage IV category of the TNM classification.
이우정, 박병우
core  

Induction treatments with and without addition of one dose anthracycline to all-trans retinoid acid and arsenic in pediatric non-high-risk acute promyelocytic leukemia: study protocol for a randomized controlled trial

Trials
Background The treatment of all-trans retinoic acid (ATRA) and arsenical agent has revolutionarily improved the prognosis of acute promyelocytic leukemia (APL) both in adults and children.
Zhong Fan, Xiu-Ya Huang, Dan-Ping Huang, Jie-Si Luo, Jia-Yin Su, Xiao-Li Zhang, Yu Li, Li-Na Wang, Cong Liang, Xue-Qun Luo, Li-Bin Huang, Yan-Lai Tang   +11 more
doaj   +1 more source

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

Molecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura, Tadahiro Kuribayashi, Johannes Brägelmann, Sachi Okawa, Masataka Taoka, Shunta Mori, Tomoka Nishimura, Takaaki Tanaka, Go Makimoto, Kiichiro Ninomiya, Kammei Rai, Eiki Ichihara, Ryohei Katayama, Katsuyuki Hotta, Masahiro Tabata, Yosuke Togashi, Yoshinobu Maeda, Martin L. Sos, Katsuyuki Kiura, Kadoaki Ohashi   +19 more
wiley   +1 more source

The impact of the interval between the induction of chemotherapy and radiotherapy on the survival of patients with nasopharyngeal carcinoma

, 2019
Shiping Yang,1,2,* Xiaoling Fu,3,* Guang Huang,2 Junni Chen,2 Shishi Luo,4 Zhenping Wang,4 Fanzhong Kong,2 Gang Wu,2 Shaomin Lin,2 Fen Wang,2 Longhua Chen1 1Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou ...
Lin S, Chen J, Fu X, Huang G, Chen L, Kong F, Wang F, Luo S, Wu G, Yang S, Wang Z   +10 more
core  

Response to induction chemotherapy according to PET/CT.

, 2018
Response to induction chemotherapy according to PET/CT.
Louise De Brot Andrade (5638139), Andrea Paiva Gadelha Guimarães (5638154), Thiago Bueno de Oliveira (5638136), Victor Hugo Fonseca de Jesus (5638130), Marclesson Santos Alves (5638133), Loureno Cezana (5638157), Eduardo Nóbrega Pereira Lima (825607), Luiz Paulo Kowalski (789354), Ulisses Ribaldo Nicolau (825606), Antônio Cássio Assis Pellizzon (5638163), Tadeu Ferreira de Paiva Jr (5638148), Paula Cacciatore Bes (5638145), Vinicius Fernando Calsavara (5638151), Gislaine Cristina Lopes Machado Porto (5638160), Genival Barbosa de Carvalho (5638166), Paula Nicole Vieira Pinto Barbosa (5223218), Virgilio Souza Silva (5638142)   +16 more
core   +1 more source